Retraction

SOX2 oncogenes amplified and operate to activate AKT signalling in gastric cancer and predict immunotherapy responsiveness

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1007/s00432-019-02878-3

Citations (21)

21
Total Citations
4
Post-Retraction
(19.0%)
17
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
1 After 2+ years
1034 Days since retraction (latest)
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Jan 2022
1034 days after retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Oct 2020
590 days after retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Sep 2019
183 days after retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Jun 2019
82 days after retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Jan 2019
45 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Jan 2019
61 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Nov 2018
130 days before retraction
Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis
Ting Li, Xujie Gao, Lei Han et al. (5 authors)
World Journal of Surgical Oncology Open Access
Published: Jun 2018
78 citations
265 days before retraction
Cancer Stem Cell–Suppressing Activity of Chrysotoxine, a Bibenzyl from<i>Dendrobium pulchellum</i>
Narumol Bhummaphan, Varisa Pongrakhananon, Boonchoo Sritularak et al. (4 authors)
Journal of Pharmacology and Experimental Therapeutics Open Access
Published: Dec 2017
26 citations
459 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Apr 2017
709 days before retraction
The dark side of SOX2: cancer - a comprehensive overview
Erin L. Wuebben, Angie Rizzino
Oncotarget Open Access
Published: Mar 2017
203 citations
716 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Jun 2016
994 days before retraction
SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells
Erin L. Wuebben, Phillip J. Wilder, Jesse L. Cox et al. (7 authors)
Oncotarget Open Access
Published: Apr 2016
33 citations
1049 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Apr 2016
1052 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Feb 2016
1130 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Dec 2015
1175 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Oct 2015
1257 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Jul 2015
1349 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Feb 2015
1499 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Feb 2015
1499 days before retraction
Paper citing SOX2 oncogenes amplified and operate to activate A...
Unknown Authors
Unknown Journal
Published: Jul 2014
1711 days before retraction
Quick Stats
Total Citations: 21
Years Since Retraction: 6.7 years
Open Access: Yes
Last Checked: Never
Related Papers
Primary hemostasis dysfunctions and bleeding risk in newly …
Journal of Cancer Research and Clinical Oncology • 2 citations
Wilms tumor-suppressing peptide inhibits proliferation and …
Journal of Cancer Research and Clinical Oncology • 6 citations
The role of lymph node dissection in the surgical treatment…
Journal of Cancer Research and Clinical Oncology • 2 citations
FXYD6 Regulates Chemosensitivity by Mediating the Expressio…
BioMed Research International • 13 citations